ESMO Young Oncologist Journal Club

The ESMO Young Oncologists Committee is proud to host the Young Oncologist Journal Club. On a regular basis (1-3 times a month), a committee member – or a specially invited young oncologists – provides you with an appraisal of an important clinical and/or translational article published in a major journal. The appraisers add their comments analysing the clinical relevance of the article and possible considerations.

Get involved by reading the review, share your thoughts and raise questions for discussion by logging in and commenting on the article. Commenting is reserved to ESMO Members only. We look forward to your input!

Submit an article


Topic Title Author
Lung and other thoracic tumours Prognostic and Predictive Value of Rare EGFR Exon 18 and Exon 20 Mutations in Advanced NSCLC Mohamed Alorabi
Gastrointestinal cancers Ramucirumab and the Evolving Role of Targeted Therapy in Advanced Gastric Cancer Adel Aref
Gastrointestinal cancers Panitumumab-Folfox4 Treatment and RAS Mutation in Colorectal Cancer Alfredo Addeo
Haematologic malignancies R-GCVP as First Line Treatment for DLBCL Patients with Cardiac Comorbidity Mohamed Alorabi
Gynaecologic malignancies Overcoming Platinum Resistance in Ovarian Cancer – The PRECEDENT Trial Rita Canario, Susana Banerjee
Lung and other thoracic tumours NSCLC Maintenance Therapy: Bevacizumab or Pemetrexed? Thiago Lins Almeida
Gastrointestinal cancers Continuation of Bevacizumab with Second-Line Chemotherapy after the Standard First-Line Bevacizumab-Containing Therapy in mCRC: What is the value of KRAS status? Adel Aref
Genitourinary cancers Castration Resistant Prostate Cancer; the Rise & Fall of Systemic Chemotherapy - Highlights from Recent Phase III Studies Omar Abdel-Rahman
Breast cancer Primary Breast Cancer During Pregnancy: Does it Affect Outcome? Carola Melcher, Michiel Strijbos
Gynaecologic malignancies How to Best Classify Endometrial Cancers? Judith Michels
Lung and other thoracic tumours A New Paradigm Shift: Platinum-Based Doublets Better than Monotherapy even in Patients with Advanced Non-Small Cell Lung Cancer and Performance Status 2 Omar Abdel-Rahman
Haematologic malignancies First-line Treatment Strategies for Advanced-Stage Follicular Lymphoma: Which is The Best One? Ozan Yazici, Omer Dizdar
Gastrointestinal cancers Cisplatin-Based Chemoradiation: In Which Setting(s) Could Cisplatin Replace Mitomycin in the Treatment of Localised Anal Squamous Cell Carcinoma? Omar Abdel-Rahman
Breast cancer Clinical Research in HER2 Positive Metastatic Breast Cancer – Ethical Issues of Trials Conducted in Low Resource Environments Felipe Ades
Breast cancer Pregnancy After Breast Cancer Could be Considered Safe Even in Women with History of Endocrine-Sensitive Breast Cancer. Matteo Lambertini